U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C6H13N
Molecular Weight 99.1741
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of CYCLOHEXYLAMINE

SMILES

NC1CCCCC1

InChI

InChIKey=PAFZNILMFXTMIY-UHFFFAOYSA-N
InChI=1S/C6H13N/c7-6-4-2-1-3-5-6/h6H,1-5,7H2

HIDE SMILES / InChI

Molecular Formula C6H13N
Molecular Weight 99.1741
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

PubMed

PubMed

TitleDatePubMed
Kinetic and equilibrium lithium acidities of arenes: theory and experiment.
2010-08-26
Over-expression of the IGI1 leading to altered shoot-branching development related to MAX pathway in Arabidopsis.
2010-08
Q344ter mutation causes mislocalization of rhodopsin molecules that are catalytically active: a mouse model of Q344ter-induced retinal degeneration.
2010-06-02
Interaction and dimerization energies in methyl-blocked alpha,gamma-peptide nanotube segments.
2010-04-22
Plasmodium falciparum spermidine synthase inhibition results in unique perturbation-specific effects observed on transcript, protein and metabolite levels.
2010-04-12
Noncovalent tripeptidyl benzyl- and cyclohexyl-amine inhibitors of the cysteine protease caspase-1.
2010-03-25
Chiral differentiation of some cyclic beta-amino acids by kinetic and fixed ligand methods.
2010-02
Automated determination of aliphatic primary amines in wastewater by simultaneous derivatization and headspace solid-phase microextraction followed by gas chromatography-tandem mass spectrometry.
2010-01-22
Synthesis of (1R,2R)- and (1S,2R)-1,2-epoxy-3-hydroxypropylphosphonates as analogues of fosfomycin.
2009-09
Design, synthesis and evaluation of a novel cyclohexanamine class of neuropeptide Y Y1 receptor antagonists.
2009-08-15
Chiral differentiation of some cyclopentane and cyclohexane beta-amino acid enantiomers through ion/molecule reactions.
2009-07
Hollow Ni-B amorphous alloy with enhanced catalytic efficiency prepared in emulsion system.
2009-06-15
High-pressure ion mobility spectrometry.
2009-05-01
Development and single-laboratory validation of an HPLC method for the determination of cyclamate sweetener in foodstuffs.
2009-05
A fritless, EOF microchip pump for high pressure pumping of aqueous and organic solvents.
2009-04-07
Microwave-assisted combinatorial synthesis of new 3-pyrimidin-5-ylpropanamides via a solvent-dependent chemoselective reaction.
2009-03-09
Synthesis and pharmacological evaluation of 3-cyclohexyl-2-substituted hydrazino-3H-quinazolin-4-ones as analgesic and anti-inflammatory agents.
2009-03
Diastereochemical differentiation of some cyclic and bicyclic beta-amino acids, via the kinetic method.
2009-01
In vitro and in vivo inhibition of plant polyamine oxidase activity by polyamine analogues.
2008-10
New 2-amino-thiazole-4-acetamides with antiplatelet activity.
2008-10
CdS/Cyclohexylamine inorganic-organic hybrid semiconductor nanofibers with strong quantum confinement effect.
2008-08
Comparison of the electronic properties, and thermodynamic and kinetic parameters of the aquation of selected platinum(II) derivatives with their anticancer IC50 indexes.
2008-08
Synthesis, characterization, antioxidant activity, and DNA-binding studies of 1-cyclohexyl-3-tosylurea and its Nd(III), Eu(III) complexes.
2008-04
Screening of 397 chemicals and development of a quantitative structure--activity relationship model for androgen receptor antagonism.
2008-04
Polyamine metabolism during sclerotial development of Sclerotinia sclerotiorum.
2008-03
Structure of cyclic dihydroxyacetone phosphate dimethyl acetal, a cyclic DHAP precursor, in the crystalline state.
2008-01-14
Differentiation of diastereomeric cyclic beta-amino acids by varying the neutral reagent in ion/molecule reactions studied by electrospray ionization Fourier transform ion cyclotron resonance mass spectrometry.
2008
Convergent and stereospecific synthesis of molecules containing alpha-functionalized guanidiniums via alpha-guanidino acids.
2007-12-07
Global expression analysis of nucleotide binding site-leucine rich repeat-encoding and related genes in Arabidopsis.
2007-10-23
Chemical analysis of acidic silicon etch solutions I. Titrimetric determination of HNO(3), HF, and H(2)SiF(6).
2007-09-15
A new diastereoselective aza-allyl conjugate addition-Michael addition-ring closure reaction sequence and its application in the construction of six contiguous stereogenic centres.
2007-09-14
Preclinical antitumor activity of the oral platinum analog satraplatin.
2007-09
Trans-platinum(II) complexes with cyclohexylamine as expectator ligand induce necrosis in tumour cells by inhibiting DNA synthesis and RNA transcription.
2007-08
A novel dicyclodextrinyl diselenide compound with glutathione peroxidase activity.
2007-08
Modeling assisted rational design of novel, potent, and selective pyrrolopyrimidine DPP-4 inhibitors.
2007-07-15
Relaxation during polymerization on slow heating and the vibrational heat capacity of the polymers.
2007-07-14
Rational design of a novel, potent, and orally bioavailable cyclohexylamine DPP-4 inhibitor by application of molecular modeling and X-ray crystallography of sitagliptin.
2007-06-15
The use of visible absorption spectra to evaluate different color reactions for the detection of cyclic ureides.
2007-06
Hydration of cyclohexylamines: CPCM calculation of hydration Gibbs energy of the conformers.
2007-05-03
Structure-activity relationship of new trans-platinum(II) and (IV) complexes with cyclohexylamine. Interference with cell cycle progression and induction of cell death.
2007-04
Novel mechanisms of platinum drug resistance identified in cells selected for resistance to JM118 the active metabolite of satraplatin.
2007-02
How polyamine synthesis inhibitors and cinnamic acid affect tropane alkaloid production.
2007-01
Prediction of estrogen receptor agonists and characterization of associated molecular descriptors by statistical learning methods.
2006-11
Interactions of platinum complexes containing cationic, bicyclic, nonplanar piperidinopiperidine ligands with biological nucleophiles.
2006-07-27
Cationic nonsymmetric transplatinum complexes with piperidinopiperidine ligands. Preparation, characterization, in vitro cytotoxicity, in vivo toxicity, and anticancer efficacy studies.
2006-07-27
From chemosensory thresholds to whole body exposures-experimental approaches evaluating chemosensory effects of chemicals.
2006-04
Structure of dihydroxyacetone phosphate dimethyl acetal, a stable dihydroxyacetone phosphate precursor, in the crystalline state.
2006-03-20
Do exogenous polyamines have an impact on the response of a salt-sensitive rice cultivar to NaCl?
2006-03
Hydrolysis process of the second generation platinum-based anticancer drug cis-amminedichlorocyclohexylamineplatinum(II).
2005-06-23
Purification and some properties of cyclohexylamine oxidase from a Pseudomonas sp.
1977-04
Patents
Substance Class Chemical
Created
by admin
on Mon Mar 31 17:33:08 GMT 2025
Edited
by admin
on Mon Mar 31 17:33:08 GMT 2025
Record UNII
I6GH4W7AEG
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
CYCLOHEXYLAMINE
HSDB   INCI   MI  
INCI  
Official Name English
CYCLOHEXYLAMINE [HSDB]
Preferred Name English
GLIPIZIDE IMPURITY B [EP IMPURITY]
Common Name English
CYCLOHEXANAMINE
Systematic Name English
CYCLOHEXYLAMINE [MI]
Common Name English
Classification Tree Code System Code
Food Contact Sustance Notif, (FCN No.) FCN NO. 1008
Created by admin on Mon Mar 31 17:33:08 GMT 2025 , Edited by admin on Mon Mar 31 17:33:08 GMT 2025
Code System Code Type Description
FDA UNII
I6GH4W7AEG
Created by admin on Mon Mar 31 17:33:08 GMT 2025 , Edited by admin on Mon Mar 31 17:33:08 GMT 2025
PRIMARY
HSDB
918
Created by admin on Mon Mar 31 17:33:08 GMT 2025 , Edited by admin on Mon Mar 31 17:33:08 GMT 2025
PRIMARY
WIKIPEDIA
CYCLOHEXYLAMINE
Created by admin on Mon Mar 31 17:33:08 GMT 2025 , Edited by admin on Mon Mar 31 17:33:08 GMT 2025
PRIMARY
MERCK INDEX
m3992
Created by admin on Mon Mar 31 17:33:08 GMT 2025 , Edited by admin on Mon Mar 31 17:33:08 GMT 2025
PRIMARY Merck Index
CAS
108-91-8
Created by admin on Mon Mar 31 17:33:08 GMT 2025 , Edited by admin on Mon Mar 31 17:33:08 GMT 2025
PRIMARY
ECHA (EC/EINECS)
203-629-0
Created by admin on Mon Mar 31 17:33:08 GMT 2025 , Edited by admin on Mon Mar 31 17:33:08 GMT 2025
PRIMARY
CHEBI
15773
Created by admin on Mon Mar 31 17:33:08 GMT 2025 , Edited by admin on Mon Mar 31 17:33:08 GMT 2025
PRIMARY
PUBCHEM
7965
Created by admin on Mon Mar 31 17:33:08 GMT 2025 , Edited by admin on Mon Mar 31 17:33:08 GMT 2025
PRIMARY
CHEBI
42939
Created by admin on Mon Mar 31 17:33:08 GMT 2025 , Edited by admin on Mon Mar 31 17:33:08 GMT 2025
PRIMARY
EPA CompTox
DTXSID1023996
Created by admin on Mon Mar 31 17:33:08 GMT 2025 , Edited by admin on Mon Mar 31 17:33:08 GMT 2025
PRIMARY
Related Record Type Details
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
Related Record Type Details
PARENT -> IMPURITY